Akgul, MahmutMacLennan, Gregory T.Cheng, Liang2019-08-152019-08-152019-09Akgul, M., MacLennan, G. T., & Cheng, L. (2019). Distinct Mutational Landscape of Inverted Urothelial Papilloma. The Journal of Pathology, 249(1), 3-5. https://doi.org/10.1002/path.5307https://hdl.handle.net/1805/20386A recent study has identified gene mutations involving the MAPK/ERK pathway, particularly the HRAS gene, in all inverted urothelial papillomas (IUPs), in the absence of pathway mutations in TERT promoter, FGFR3, and TP53/RB1genes. Neither recurrence nor progression was observed in IUPs. These data support several longstanding hypotheses: (1) IUPs are benign and do not recur or progress; (2) they harbor mutations that are different from those of urothelial carcinoma; and (3) they arise through different molecular mechanisms than low‐ or high‐grade urothelial carcinoma. As the most critical differential diagnosis in this context is inverted‐type urothelial carcinoma, more comprehensive studies are needed to compare and contrast these entities.enPublisher Policyurinary bladderinverted urothelial papillomamolecular geneticsArticle